Pfizer ends neuroscience discovery programme, including research into Alzheimer’s disease treatment – Alzheimer’s Society comment

Pfizer has announced that it will be ending its neuroscience discovery and early development efforts, an area which includes research into drug development for Alzheimer’s disease.

from Dementia Big http://ift.tt/2CVOJgD via alcoholic dementia
http://ift.tt/2CVYhbz